MedPath

â??ROLE OF SHWADAMSHTRADI KWATH IN THE MANAGEMENT OF MUTRASHMARI WITH SPECIAL REFERENCE TO UROLITHIASISâ??A PROSPECTIVE CLINICAL TRIA

Phase 2
Conditions
Health Condition 1: null- Urolithiatic Patient with Kidney stone size up to 15 mm, Ureteric Stone size up to 10 mm, Urinary Bladder Stone size up to 15 mm
Registration Number
CTRI/2018/05/013612
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

INCLUSION CRITERIA:

1. Age â?? 16-70 years

2. Kidney stone size up to 15 mm

3. Ureteric Stone size up to 10 mm

4. Urinary Bladder Stone size up to 15 mm

5. Radiographic and /or USG evidence of the stone.

6. Urolithiatic patients with controlled Hypertension and Diabetic Mellitus

Exclusion Criteria

EXCLUSION CRITERIA:

1. Renal Failure

2. Gross Hydronephrosis

3. Kidney stone and Bladder Stone size more than 15 mm

4. Ureteric stone Size more than 10 mm

5. Severe Haematuria

6. Acute pain abdomen

7. Known cases of malignancy

8. Known cases of Tuberculosis

9. Known cases of HIV, VDRL and Hep-B positive

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PRIMARY ENDPOINT <br/ ><br>ï?· Relieving in cardinal sign and symptoms of Urolithiasis <br/ ><br> <br/ ><br>Timepoint: At the time of complition of study <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
SECONDARY ENDPOINT <br/ ><br>ï?· Disintegrating and expulsive effectTimepoint: At the time of complition of study
© Copyright 2025. All Rights Reserved by MedPath